Last week, readers were most interested in a story about a deal between QuidelOrtho and Shenzhen Lifotronic Technology covering immunoassays.
Labcorp said it will be using the company's FDA-cleared AISight Dx platform across its national network of anatomic pathology labs and hospital collaborations.
The company plans to begin using the instrument in its Burlington, North Carolina, lab in the first quarter of the year and ...
The transition from testing the dead to testing the living is the latest example of how genomics is expanding horizons for ...
The cleared assays included point-of-care and home tests for infectious and chronic diseases and drugs of abuse.
The agreement pertains to multiple immunoassay analyzers and test menus that QuidelOrtho expects will increase its competitiveness in international tenders.
NEW YORK – Lex Diagnostics said on Monday that it has obtained 510 (k) clearance and CLIA waiver from the US Food and Drug Administration for its Velo point-of-care molecular diagnostic system and an ...
The test runs on the company's OneBreath platform and is designed to assess a patient's risk for postoperative pneumonia.
NEW YORK — Hardy Diagnostics said on Wednesday that two of its immunoassays for drug-resistant pathogen detection have been designated breakthrough devices by the US Food and Drug Administration. Both ...
The automated image assessment software uses artificial intelligence to sort images of bacterial culture plates.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results